{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:16:48Z","timestamp":1787829408430,"version":"build-2784847793"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001428","name":"Amity University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009374","name":"Amity Institute of Biotechnology, Amity University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/PURSE\/2021\/77"],"award-info":[{"award-number":["SR\/PURSE\/2021\/77"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.abb.2025.110500","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:20:52Z","timestamp":1749320452000},"page":"110500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Protein misfolding, aggregation and other factors determining the amyloidogenic landscape of human leucocyte chemotaxin-2: A review"],"prefix":"10.1016","volume":"771","author":[{"given":"Akhilesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshan Singh","family":"Lakhawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashdeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0359-744X","authenticated-orcid":false,"given":"Pushpender Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6369","key":"10.1016\/j.abb.2025.110500_bib1","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science"},{"issue":"5766","key":"10.1016\/j.abb.2025.110500_bib2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1126\/science.1124514","article-title":"Progressive disruption of cellular protein folding in models of polyglutamine diseases","volume":"311","author":"Gidalevitz","year":"2006","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.abb.2025.110500_bib3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.devcel.2015.01.022","article-title":"Cellular functions of the amyloid precursor protein from development to dementia","volume":"32","author":"van der Kant","year":"2015","journal-title":"Dev. Cell"},{"issue":"68","key":"10.1016\/j.abb.2025.110500_bib4","first-page":"1","article-title":"Protein folding and its links with human disease","author":"Dobson","year":"2001","journal-title":"Biochem. Soc. Symp."},{"issue":"2","key":"10.1016\/j.abb.2025.110500_bib5","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a023572","article-title":"The three-dimensional structures of amyloids","volume":"9","author":"Riek","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7043","key":"10.1016\/j.abb.2025.110500_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature03680","article-title":"Structure of the cross-beta spine of amyloid-like fibrils","volume":"435","author":"Nelson","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.abb.2025.110500_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/07853898909149186","article-title":"Systemic and cerebral amyloidosis","volume":"21","author":"Frangione","year":"1989","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.abb.2025.110500_bib8a","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0197-4580(02)00076-3","article-title":"Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms","volume":"23","author":"Forloni","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.abb.2025.110500_bib8b","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ibneur.2022.09.007","article-title":"The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease","volume":"13","author":"Caligiore","year":"2022","journal-title":"IBRO Neurosci Rep"},{"issue":"17","key":"10.1016\/j.abb.2025.110500_bib9","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/anie.200802808","article-title":"Alzheimer's disease: from pathology to therapeutic approaches","volume":"48","author":"Jakob-Roetne","year":"2009","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"9","key":"10.1016\/j.abb.2025.110500_bib10","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1039\/b807980n","article-title":"The chemistry of Alzheimer's disease","volume":"38","author":"Rauk","year":"2009","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.abb.2025.110500_bib11","doi-asserted-by":"crossref","DOI":"10.1088\/2050-6120\/4\/3\/034010","article-title":"Combined thioflavin T-Congo red fluorescence assay for amyloid fibril detection","volume":"4","author":"Girych","year":"2016","journal-title":"Methods Appl. Fluoresc."},{"issue":"55","key":"10.1016\/j.abb.2025.110500_bib12","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1039\/D0CC01161D","article-title":"Binding modes of thioflavin T and Congo red to the fibril structure of amyloid-\u03b2(1-42)","volume":"56","author":"Frieg","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.abb.2025.110500_bib13","series-title":"Thioflavin T Stain: an Easier and More Sensitive Method for Amyloid Detection","first-page":"187","author":"Picken","year":"2012"},{"issue":"4","key":"10.1016\/j.abb.2025.110500_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1017\/S0033583508004654","article-title":"Protein folding and misfolding: mechanism and principles","volume":"40","author":"Englander","year":"2007","journal-title":"Q. Rev. Biophys."},{"issue":"41","key":"10.1016\/j.abb.2025.110500_bib15","first-page":"22","article-title":"How to fold graciously","volume":"67","author":"Levinthal","year":"1969","journal-title":"Mossbauer Spectroscopy in Biological Systems Proceedings"},{"issue":"2","key":"10.1016\/j.abb.2025.110500_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ki.2008.152","article-title":"Leukocyte chemotactic factor 2: a novel renal amyloid protein","volume":"74","author":"Benson","year":"2008","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.abb.2025.110500_bib17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ki.2010.9","article-title":"Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies","volume":"77","author":"Larsen","year":"2010","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.abb.2025.110500_bib18","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.abb.2025.110500_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/13506129.2016.1145110","article-title":"Prevalence and organ distribution of leukocyte chemotactic factor 2 amyloidosis (ALECT2) among decedents in New Mexico","volume":"23","author":"Larsen","year":"2016","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.abb.2025.110500_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ajcp\/aqac138","article-title":"Leukocyte chemotactic factor 2 amyloidosis (ALECT2) distribution in a Mexican population","volume":"159","author":"de la Cruz Jasso","year":"2023","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.abb.2025.110500_bib21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/ckj\/sft126","article-title":"Leukocyte chemotactic factor 2 (LECT2) amyloidosis presenting as pulmonary-renal syndrome: a case report and review of the literature","volume":"6","author":"Khalighi","year":"2013","journal-title":"Clin Kidney J"},{"issue":"6","key":"10.1016\/j.abb.2025.110500_bib22","first-page":"276","article-title":"Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver","volume":"7","author":"Okumura","year":"2013","journal-title":"Biosci Trends"},{"issue":"5","key":"10.1016\/j.abb.2025.110500_bib23","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2337\/db13-0728","article-title":"LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance","volume":"63","author":"Lan","year":"2014","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.abb.2025.110500_bib24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1053\/j.ajkd.2010.08.013","article-title":"Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series","volume":"56","author":"Murphy","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.abb.2025.110500_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.643357","article-title":"Taxifolin: a potential therapeutic agent for cerebral amyloid angiopathy","volume":"12","author":"Saito","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.abb.2025.110500_bib26","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1007\/s00018-019-03225-y","article-title":"Chondromodulin-1 in health, osteoarthritis, cancer, and heart disease","volume":"76","author":"Zhu","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"16","key":"10.1016\/j.abb.2025.110500_bib27","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1242\/dev.024539","article-title":"Maternal depletion of CTCF reveals multiple functions during oocyte and preimplantation embryo development","volume":"135","author":"Wan","year":"2008","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.abb.2025.110500_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/art.23215","article-title":"Suppressive role of leukocyte cell-derived chemotaxin 2 in mouse anti-type II collagen antibody-induced arthritis","volume":"58","author":"Okumura","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.abb.2025.110500_bib29","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1172\/JCI43937","article-title":"Oncogenic \u03b2-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice","volume":"122","author":"Anson","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.abb.2025.110500_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.11.010","article-title":"Regulation of neurite extension by expression of LECT2 and neurotrophins based on findings in LECT2-knockout mice","volume":"1311","author":"Koshimizu","year":"2010","journal-title":"Brain Res."},{"issue":"92","key":"10.1016\/j.abb.2025.110500_bib31","doi-asserted-by":"crossref","first-page":"36430","DOI":"10.18632\/oncotarget.26335","article-title":"Lect2 deficiency is characterised by altered cytokine levels and promotion of intestinal tumourigenesis","volume":"9","author":"Greenow","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.abb.2025.110500_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.749648","article-title":"LECT2, A novel and direct biomarker of liver fibrosis in patients with CHB","volume":"8","author":"Xu","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"10","key":"10.1016\/j.abb.2025.110500_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102442","article-title":"Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinoma","volume":"298","author":"Chu","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2025.110500_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156697","article-title":"Updates on the role of leukocyte cell-derived chemotaxin-2 in inflammation regulation and immunomodulation","volume":"181","author":"Lao","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.abb.2025.110500_bib35","article-title":"Global research trends and hotspots for leukocyte cell-derived chemotaxin-2 from the past to 2023: a combined bibliometric review","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.abb.2025.110500_bib36","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.26738","article-title":"Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment","volume":"59","author":"Chen","year":"2014","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.abb.2025.110500_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/bs.acc.2022.07.003","article-title":"Biomarkers in metabolic syndrome","volume":"111","author":"Cho","year":"2022","journal-title":"Adv. Clin. Chem."},{"issue":"24","key":"10.1016\/j.abb.2025.110500_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12247544","article-title":"Association between leukocyte cell-derived chemotaxin 2 and metabolic and renal diseases in a Geriatric population: a pilot study","volume":"12","author":"Kuzan","year":"2023","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.abb.2025.110500_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/liv.14816","article-title":"Leukocyte cell-derived chemotaxin 2 promotes the development of nonalcoholic fatty liver disease through STAT-1 pathway in mice","volume":"41","author":"Wang","year":"2021","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.abb.2025.110500_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/labmed\/lmac080","article-title":"Serum leukocyte cell-derived chemotaxin 2 (LECT2) level is associated with osteoporosis","volume":"54","author":"Wang","year":"2023","journal-title":"Lab. Med."},{"issue":"5","key":"10.1016\/j.abb.2025.110500_bib41","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00592-024-02242-z","article-title":"Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome","volume":"61","author":"Zheng","year":"2024","journal-title":"Acta Diabetol."},{"issue":"7","key":"10.1016\/j.abb.2025.110500_bib42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41388-023-02918-w","article-title":"Loss of LECT2 promotes ovarian cancer progression by inducing cancer invasiveness and facilitating an immunosuppressive environment","volume":"43","author":"Wu","year":"2024","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.abb.2025.110500_bib43","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4103\/1319-2442.284027","article-title":"A case of renal and splenic LECT 2 amyloidosis: a recently recognized cause of renal and systemic amyloidosis","volume":"31","author":"Shye","year":"2020","journal-title":"Saudi J Kidney Diseases Transplantation"},{"issue":"5","key":"10.1016\/j.abb.2025.110500_bib44","first-page":"558","article-title":"LECT2- associated renal amyloidosis (ALECT2): a case report","volume":"38","author":"Ortega","year":"2018","journal-title":"Nefrologia"},{"issue":"6","key":"10.1016\/j.abb.2025.110500_bib45","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/ckj\/sft126","article-title":"Leukocyte chemotactic factor 2 (LECT2) amyloidosis presenting as pulmonary-renal syndrome: a case report and review of the literature","volume":"6","author":"Khalighi","year":"2013","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1016\/j.abb.2025.110500_bib46","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/geno.2000.6499","article-title":"A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein AII gene","volume":"72","author":"Benson","year":"2001","journal-title":"Genomics"},{"issue":"10","key":"10.1016\/j.abb.2025.110500_bib47","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2013-07-517938","article-title":"Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States","volume":"123","author":"Mereuta","year":"2014","journal-title":"Blood"},{"issue":"sup1","key":"10.1016\/j.abb.2025.110500_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/13506129.2011.574354084","article-title":"Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis","volume":"18","author":"Murphy","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.abb.2025.110500_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-pathol-052016-100200","article-title":"Amyloidosis: insights from proteomics","volume":"12","author":"Dogan","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.abb.2025.110500_bib50","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2215\/CJN.12551214","article-title":"Leukocyte cell-derived chemotaxin 2-associated amyloidosis: a recently recognized disease with distinct clinicopathologic characteristics","volume":"10","author":"Nasr","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.abb.2025.110500_bib51","first-page":"266","article-title":"Mixed leukocyte cell-derived chemotaxin 2 and amyloid A renal amyloidosis in a Kazakh-German patient","volume":"10","author":"G\u00f6decke","year":"2017","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.abb.2025.110500_bib52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/cts.12469","article-title":"Leukocyte cell-derived chemotaxin-2: it's role in pathophysiology and future in clinical medicine","volume":"10","author":"Slowik","year":"2017","journal-title":"Clin. Transl Sci."},{"issue":"5","key":"10.1016\/j.abb.2025.110500_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107231","article-title":"Mimicking kidney flow shear efficiently induces aggregation of LECT2, a protein involved in renal amyloidosis","volume":"300","author":"Ha","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.abb.2025.110500_bib54","doi-asserted-by":"crossref","first-page":"17133","DOI":"10.1074\/jbc.M116.720375","article-title":"Crystal structure of human leukocyte cell-derived chemotaxin 2 (LECT2) reveals a mechanistic basis of functional evolution in a mammalian protein with an M23 metalloendopeptidase fold","volume":"291","author":"Zheng","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2025.110500_bib55","doi-asserted-by":"crossref","first-page":"41232","DOI":"10.1074\/jbc.M110.156273","article-title":"Bacillus subtilis CwlP of the SP-\u03b2 prophage has two novel peptidoglycan hydrolase domains, muramidase and cross-linkage digesting DD-endopeptidase","volume":"285","author":"Sudiarta","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2025.110500_bib56","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.1997.5101880.x","article-title":"The lytic enzyme of the pneumococcal phage Dp-1: a chimeric lysin of intergeneric origin","volume":"25","author":"Sheehan Mm Garcia","year":"1997","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.abb.2025.110500_bib57","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1128\/aem.61.11.4099-4104.1995","article-title":"Identification of prophage genes expressed in lysogens of the Lactococcus lactis bacteriophage BK5-T","volume":"61","author":"Boyce","year":"1995","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.abb.2025.110500_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034052","article-title":"Mycobacteriophage endolysins: diverse and modular enzymes with multiple catalytic activities","volume":"7","author":"Payne","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.abb.2025.110500_bib59","series-title":"Molecular E\u0160olution and Phylogenetics","year":"2000"},{"issue":"7","key":"10.1016\/j.abb.2025.110500_bib60","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/molbev\/msab120","article-title":"MEGA11: molecular evolutionary genetics analysis version 11","volume":"38","author":"Tamura","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.abb.2025.110500_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100446","article-title":"Loss of bound zinc facilitates amyloid fibril formation of leukocyte-cell-derived chemotaxin 2 (LECT2)","volume":"296","author":"Ha","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2025.110500_bib62","first-page":"2022","article-title":"An amyloidosis-associated polymorphism does not alter LECT2 stability in vitro","author":"Belonogov","year":"2022","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.abb.2025.110500_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005004","article-title":"Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase","volume":"4","author":"Oztug Durer","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.abb.2025.110500_bib64","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jsb.2019.06.001","article-title":"Delving into the amyloidogenic core of human leukocyte chemotactic factor 2","volume":"207","author":"Tsiolaki","year":"2019","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.abb.2025.110500_bib65","article-title":"The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: from mechanisms to therapeutic potential","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"issue":"33","key":"10.1016\/j.abb.2025.110500_bib66","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2320510121","article-title":"Leveraging a large language model to predict protein phase transition: a physical, multiscale, and interpretable approach","volume":"121","author":"Frank","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.abb.2025.110500_bib67","article-title":"Meeting the moment: addressing barriers and facilitating clinical adoption of artificial intelligence in medical diagnosis","volume":"2022","author":"Adler-Milstein","year":"2022","journal-title":"NAM Perspect."},{"issue":"5","key":"10.1016\/j.abb.2025.110500_bib68","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.gpb.2022.11.014","article-title":"Protein structure prediction: challenges, advances, and the shift of research paradigms","volume":"21","author":"Huang","year":"2023","journal-title":"Genom. Proteom. Bioinform."},{"issue":"3365","key":"10.1016\/j.abb.2025.110500_bib69","first-page":"23","article-title":"Investigating protein-folding becomes easier with AI","volume":"252","author":"Sparkes","year":"2021","journal-title":"New Scientist"},{"issue":"11","key":"10.1016\/j.abb.2025.110500_bib70","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.str.2023.08.007","article-title":"Cryo-EM structure of a human LECT2 amyloid fibril reveals a network of polar ladders at its core","volume":"31","author":"Richards","year":"2023","journal-title":"Structure"},{"key":"10.1016\/j.abb.2025.110500_bib71","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12551-019-00571-w","article-title":"Cryo-electron microscopy: an introduction to the technique, and considerations when working to establish a national facility","volume":"11","author":"Bhella","year":"2019","journal-title":"Biophys Rev"},{"key":"10.1016\/j.abb.2025.110500_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultramic.2022.113628","article-title":"A new TCAD simulation method for direct CMOS electron detectors optimization","volume":"243","author":"Marcelot","year":"2023","journal-title":"Ultramicroscopy"},{"issue":"5","key":"10.1016\/j.abb.2025.110500_bib73","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41408-021-00483-7","article-title":"Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021","volume":"11","author":"Hasib Sidiqi","year":"2021","journal-title":"Blood Cancer J."},{"issue":"6","key":"10.1016\/j.abb.2025.110500_bib74","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1053\/j.ajkd.2015.08.016","article-title":"Renal AH amyloidosis associated with a truncated immunoglobulin heavy chain undetectable by immunostaining","volume":"66","author":"Manabe","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"11","key":"10.1016\/j.abb.2025.110500_bib75","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1016\/j.clml.2020.06.017","article-title":"How we manage systemic immunoglobulin heavy chain amyloidosis (AH amyloidosis) and immunoglobulin heavy-and-light-chain amyloidosis (AH\/AL amyloidosis)","volume":"20","author":"Chaulagain","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"4","key":"10.1016\/j.abb.2025.110500_bib76","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s40620-023-01845-z","article-title":"Tocilizumab (anti-IL-6) treatment for AA renal amyloidosis in a patient with advanced chronic kidney disease, a case report","volume":"37","author":"Seneschall","year":"2024","journal-title":"J. Nephrol."},{"issue":"11","key":"10.1016\/j.abb.2025.110500_bib77","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.abb.2025.110500_bib78","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1021\/acschemneuro.1c00235","article-title":"Dual inhibitors of amyloid-\u03b2 and tau aggregation with amyloid-\u03b2 disaggregating properties: extended in cellulo, in silico, and kinetic studies of multifunctional anti-Alzheimer's agents","volume":"12","author":"Pasieka","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"10.1016\/j.abb.2025.110500_bib79","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/bph.16161","article-title":"Astrocyte-derived lactoferrin reduces \u03b2-amyloid burden by promoting the interaction between p38 kinase and PP2A phosphatase in male APP\/PS1 transgenic mice","volume":"181","author":"Fan","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.abb.2025.110500_bib80","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2353\/jmoldx.2009.080161","article-title":"Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene","volume":"11","author":"Eriksson","year":"2009","journal-title":"J. Mol. Diagn."},{"issue":"6","key":"10.1016\/j.abb.2025.110500_bib81","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ekir.2017.07.009","article-title":"Hereditary renal amyloidosis associated with a novel apolipoprotein A-II variant","volume":"2","author":"Prokaeva","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.abb.2025.110500_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140903","article-title":"Disrupting the DREAM transcriptional repressor complex induces apolipoprotein overexpression and systemic amyloidosis in mice","volume":"131","author":"Perampalam","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.abb.2025.110500_bib83","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpj.2015.11.007","article-title":"Apolipoprotein C-II adopts distinct structures in complex with micellar and submicellar forms of the amyloid-inhibiting lipid-mimetic dodecylphosphocholine","volume":"110","author":"Ryan","year":"2016","journal-title":"Biophys. J."},{"key":"10.1016\/j.abb.2025.110500_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10353","article-title":"D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile","volume":"7","author":"Valleix","year":"2016","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.abb.2025.110500_bib85","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/dc16-0126","article-title":"Antisense-mediated lowering of plasma apolipoprotein C-III by volanesorsen improves dyslipidemia and insulin sensitivity in type 2 diabetes","volume":"39","author":"Digenio","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.abb.2025.110500_bib86","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s11010-021-04085-6","article-title":"Aggregation of gelsolin wild-type and G167K\/R, N184K, and D187N\/Y mutant peptides and inhibition","volume":"476","author":"Ahmad","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.abb.2025.110500_bib87","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.tibtech.2018.12.005","article-title":"CRISPR\/Cas systems towards next-generation biosensing","volume":"37","author":"Li","year":"2019","journal-title":"Trends Biotechnol."},{"issue":"2","key":"10.1016\/j.abb.2025.110500_bib88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000479678","article-title":"Leukocyte cell-derived chemotaxin 2-associated renal amyloidosis: a case report","volume":"7","author":"Kaur","year":"2017","journal-title":"Case Rep. Nephrol. Dial."},{"issue":"10","key":"10.1016\/j.abb.2025.110500_bib89","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.ekir.2021.07.014","article-title":"Fibrinogen A alpha-chain amyloidosis associated with a novel variant in a Chinese family","volume":"6","author":"Jin","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.abb.2025.110500_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104806","article-title":"The effect of three polyphenols and some other antioxidant substances on amyloid fibril formation by Human cystatin C","volume":"140","author":"Jahi\u0107","year":"2020","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.abb.2025.110500_bib91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-003-0783-1","article-title":"Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain","volume":"107","author":"Akiyama","year":"2004","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.abb.2025.110500_bib92","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/jnen\/61.3.254","article-title":"Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta","volume":"61","author":"Holton","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.abb.2025.110500_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101089","article-title":"A familial Danish dementia rat shows impaired presynaptic and postsynaptic glutamatergic transmission","volume":"297","author":"Yin","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.abb.2025.110500_bib94","doi-asserted-by":"crossref","first-page":"10481","DOI":"10.1073\/pnas.1804198115","article-title":"Small molecule inhibits \u03b1-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons","volume":"115","author":"Pujols","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.abb.2025.110500_bib95","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.25775","article-title":"Nilotinib effects on safety, tolerability, and biomarkers in Alzheimer's disease","volume":"88","author":"Turner","year":"2020","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.abb.2025.110500_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006826","article-title":"A novel Gerstmann-Str\u00e4ussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS alleles","volume":"14","author":"Mercer","year":"2018","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.abb.2025.110500_bib97","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1053\/j.ajkd.2016.09.027","article-title":"Kidney involvement in systemic calcitonin amyloidosis associated with medullary thyroid carcinoma","volume":"69","author":"Koopman","year":"2017","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.abb.2025.110500_bib98","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1038\/s41467-022-32688-0","article-title":"Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly","volume":"13","author":"Ta\u015f","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.abb.2025.110500_bib99","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2798269","article-title":"Islet amyloid polypeptide: structure, function, and pathophysiology","volume":"2016","author":"Akter","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"3","key":"10.1016\/j.abb.2025.110500_bib100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4103\/ajns.AJNS_127_19","article-title":"Pituitary prolactinoma with amyloid deposits: surgery or dopamine agonists? Review of previous reports and new recommendations for management","volume":"14","author":"Prabhu","year":"2019","journal-title":"Asian J. Neurosurg."},{"key":"10.1016\/j.abb.2025.110500_bib101","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijbiomac.2017.11.168","article-title":"Inhibition of insulin amyloid fibrillation by Morin hydrate","volume":"108","author":"Patel","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"14","key":"10.1016\/j.abb.2025.110500_bib102","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142501","article-title":"Surfactant protein C mutation links postnatal type 2 cell dysfunction to adult disease","volume":"6","author":"Sitaraman","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.abb.2025.110500_bib103","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/13506129.2020.1811962","article-title":"Proteomic analysis shows that the main constituent of subepidermal localised cutaneous amyloidosis is not galectin-7","volume":"28","author":"Chapman","year":"2021","journal-title":"Amyloid"},{"issue":"9","key":"10.1016\/j.abb.2025.110500_bib104","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1096\/fj.10-155622","article-title":"A new amyloidosis caused by fibrillar aggregates of mutated corneodesmosin","volume":"24","author":"Caubet","year":"2010","journal-title":"Faseb j"},{"issue":"7938","key":"10.1016\/j.abb.2025.110500_bib105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41586-022-05440-3","article-title":"Medin co-aggregates with vascular amyloid-\u03b2 in Alzheimer's disease","volume":"612","author":"Wagner","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.abb.2025.110500_bib106","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41598-020-60944-0","article-title":"Effect of osmolytes on in-vitro aggregation properties of peptides derived from TGFBIp","volume":"10","author":"Venkatraman","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.abb.2025.110500_bib107","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.LAB.0000017170.26718.89","article-title":"A novel localized amyloidosis associated with lactoferrin in the cornea","volume":"82","author":"Ando","year":"2002","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.abb.2025.110500_bib108","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0714.2011.01079.x","article-title":"Expression of odontogenic ameloblast-associated protein, amelotin, ameloblastin, and amelogenin in odontogenic tumors: immunohistochemical analysis and pathogenetic considerations","volume":"41","author":"Crivelini","year":"2012","journal-title":"J. Oral Pathol. Med."},{"issue":"4","key":"10.1016\/j.abb.2025.110500_bib109","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/13506129.2022.2101920","article-title":"Detection of semenogelin 1 amyloidosis through immunohistochemical staining with novel antiserum developed based on mass spectrometric peptide mapping analysis","volume":"29","author":"Tasaki","year":"2022","journal-title":"Amyloid"},{"issue":"8","key":"10.1016\/j.abb.2025.110500_bib110","article-title":"A blast from the past: abdominal wall amyloidosis due to Enfuvirtide injections","volume":"15","author":"Costiniuk","year":"2023","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.abb.2025.110500_bib111","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.carpath.2006.01.005","article-title":"Patterns of isolated atrial amyloid: a study of 100 hearts on autopsy","volume":"15","author":"Steiner","year":"2006","journal-title":"Cardiovasc. Pathol."},{"issue":"4","key":"10.1016\/j.abb.2025.110500_bib112","first-page":"387","article-title":"Isolated atrial amyloidosis and the importance of molecular classification","volume":"26","author":"Podduturi","year":"2013","journal-title":"SAVE Proc."},{"issue":"2","key":"10.1016\/j.abb.2025.110500_bib113","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1677\/jme.1.01530","article-title":"Multiple plasma proteins control atrial natriuretic peptide (ANP) aggregation","volume":"33","author":"Torricelli","year":"2004","journal-title":"J. Mol. Endocrinol."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125002139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125002139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T07:56:05Z","timestamp":1752566165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986125002139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":114,"alternative-id":["S0003986125002139"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2025.110500","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein misfolding, aggregation and other factors determining the amyloidogenic landscape of human leucocyte chemotaxin-2: A review","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2025.110500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110500"}}